Motus GI Holdings Inc. Stock News

Motus GI (NASDAQ: MOTS ) stock is falling on Friday following a warning that the medical technology company is in danger of being delisted. Motus GI got a delisting notice from the Listing Qualificat

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Lancaster Colony (LANC), On Holding (ONON), Rent the Runway (RENT), 5E Advanced Materials (FEAM)

Motus GI (NASDAQ: MOTS ) stock is falling on Tuesday after the medical technology company announced the pricing of its shares in a public offering. This has the company offering 3,333,334 shares of M

FORT LAUDERDALE, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic out

TRDA, LPRO, TBBK, BMTX and MOTS have been added to the Zacks Rank #1 (Strong Buy) List on July 21, 2023.

Motus GI (NASDAQ: MOTS ) stock is slipping on Friday after the medical technology company announced a private placement. This has Motus GI offering 4,142,012 shares of MOTS stock for $0.845 each.

Motus GI Holdings, Inc. (MOTS) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to loss of $1.80 per share a year ago.

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 36.80% and 72.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the st

Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday. Stifel cut Neoleukin Th

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.63% and 14.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st

FORT LAUDERDALE, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions tha

Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 9.63% and 14.72%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st

Motus GI Holdings, Inc. (NASDAQ:MOTS ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Garth Russell - Managing Director-LifeSci Advisors, LLC Tim Moran - Chief Exec

Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 91.67% and 9.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead

Talkspace, Inc. (TALK) delivered earnings and revenue surprises of 15.38% and 2.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?